- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06486831
The Effect of Stress Ball in Reducing Anxiety and Fear in 6-12 Year Old Children (TSA-2023-12759)
June 27, 2024 updated by: Zülbiye demir barbak, Ataturk University
The Effect of Stress Ball in Reducing Anxiety and Fear During Plastering Procedure in Extremity Fractures in Children Aged 6-12 Years
The aim of this study was to determine the effect of stress ball application on procedure-related anxiety and fear during plaster cast procedure in children aged 6-12 years.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Children aged 6-12 years will be randomly divided into two groups: stress ball and control group.
Interventions will be applied 1 time per day (2 sessions) for 2 days.
Children in the experimental group will be given a stress ball during the plaster procedure and will be asked to squeeze it during the procedure.
Children will be assessed before, during and after the intervention.
Fear and anxiety related to the cast procedure will be assessed using the Children's Fear Scale, and the Children's Anxiety Scale - Statefulness Scale.
In addition, children's heart rate, respiration, blood pressure and SPO2 will be measured.
Study Type
Interventional
Enrollment (Estimated)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zülbiye DEMİR BARBAK, 1
- Phone Number: (442) 231 5821
- Email: zulbiye.demir@atauni.edu.tr
Study Contact Backup
- Name: Sultan Esra TEDİK, 2
- Phone Number: (442) 231 2757
- Email: esra.tedik@atauni.edu.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age between 6 and 12 years (over 12 years old)
- Absence of any physical and mental illness,
- Not having taken analgesics in the last six hours
- Hospitalization was for diagnostic or therapeutic purposes
- The child and parents are comfortable speaking and understanding Turkish.
Exclusion Criteria:
- Children hospitalized for surgery will not be included in the study.
- Those who are outside the inclusion criteria will not be included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Routine Plaster intervention will be applied to the control group.
No action will be taken.
|
|
|
Experimental: Experimental Group
During the plaster intervention process, the experimental group will squeeze the stress ball.
|
The child and parents will be taken to the procedure room for the casting procedure.
The plastering process in children takes an average of 10-15 minutes.
In the experimental group, the stress ball selected by the child will be started 1-2 minutes before the casting process and will be watched for an average of 10 minutes.
If the procedure is prolonged, the time for squeezing and playing with the stress ball will be extended.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Identification Form
Time Frame: baseline
|
In this form, there are questions about the child's age, gender, weight, age of the mother and father, presence of long-term illness, previous hospitalization status and reason, previous surgery status, presence of medication on continuous use, analgesic intake in the last 6 hours.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's Fear Scale (CFS)
Time Frame: baseline
|
The CFS, which was first used in 2003, is a scale with proven validity and reliability developed to assess the child's fear/anxiety and its level.
The scale includes five different facial expressions, with no fear/anxiety at one end and very intense fear/anxiety at the other end, and is evaluated on a 0-4 point scale.
0: no fear/anxiety, 4: extreme fear and anxiety.
|
baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Anxiety Scale-Dispositional (CAS-D)
Time Frame: Baseline
|
The CAS-D is shaped like a thermometer with a bulb at the bottom and horizontal lines with intervals going upwards.
It is intended for children aged 4-10 years.
The scale instructs children to "Imagine that all your anxious or angry feelings are at the bulb or bottom of the thermometer".
Following the data collection, two members of the research team review and score the child's CAS-D scores.
The score can range from 0 to 10.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Orhan DELİCE, 3, Erzurum City Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 20, 2024
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
March 20, 2025
Study Registration Dates
First Submitted
June 27, 2024
First Submitted That Met QC Criteria
June 27, 2024
First Posted (Actual)
July 5, 2024
Study Record Updates
Last Update Posted (Actual)
July 5, 2024
Last Update Submitted That Met QC Criteria
June 27, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TSA-2023-12759
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.